Biologic Therapy in Asthma — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Severe allergic asthma uncontrolled despite high-dose ICS/LABA with optimised modifiable factors
Biologic therapies (omalizumab for allergic asthma, mepolizumab/dupilumab for eosinophilic asthma) are indicated for severe asthma uncontrolled on step 4/5 therapy after confirming adherence, technique, and managing comorbidities.
Reference: National Asthma Council Australia – 2024 – Australian Asthma Handbook